Pacer Advisors Inc. increased its holdings in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 5.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,481 shares of the semiconductor company’s stock after buying an additional 1,173 shares during the period. Pacer Advisors Inc.’s holdings in Synopsys were worth $10,426,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also added to or reduced their stakes in the company. Parnassus Investments LLC bought a new position in shares of Synopsys in the third quarter worth $633,469,000. Edgewood Management LLC boosted its stake in shares of Synopsys by 18.9% in the 3rd quarter. Edgewood Management LLC now owns 3,069,848 shares of the semiconductor company’s stock valued at $1,554,540,000 after purchasing an additional 487,025 shares in the last quarter. Van ECK Associates Corp increased its holdings in shares of Synopsys by 26.5% during the third quarter. Van ECK Associates Corp now owns 1,605,001 shares of the semiconductor company’s stock worth $791,923,000 after buying an additional 335,993 shares in the last quarter. Impax Asset Management Group plc raised its holdings in Synopsys by 120.2% in the 3rd quarter. Impax Asset Management Group plc now owns 490,723 shares of the semiconductor company’s stock valued at $248,497,000 after buying an additional 267,836 shares during the last quarter. Finally, Wellington Management Group LLP lifted its holdings in shares of Synopsys by 32.5% during the third quarter. Wellington Management Group LLP now owns 1,048,709 shares of the semiconductor company’s stock worth $531,056,000 after purchasing an additional 257,526 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.
Insider Buying and Selling
In related news, CRO Richard S. Mahoney sold 20,838 shares of the firm’s stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the completion of the sale, the executive now owns 1,460 shares in the company, valued at approximately $738,774.60. This trade represents a 93.45 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.66% of the stock is owned by corporate insiders.
Analyst Ratings Changes
Check Out Our Latest Analysis on Synopsys
Synopsys Trading Up 3.0 %
Shares of NASDAQ:SNPS opened at $526.12 on Wednesday. Synopsys, Inc. has a 1-year low of $457.52 and a 1-year high of $629.38. The stock has a market cap of $81.33 billion, a PE ratio of 36.23, a price-to-earnings-growth ratio of 3.57 and a beta of 1.12. The stock’s fifty day simple moving average is $518.41 and its two-hundred day simple moving average is $522.22.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More
- Five stocks we like better than Synopsys
- 3 Monster Growth Stocks to Buy Now
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What Are Dividend Contenders? Investing in Dividend Contenders
- What Does the Future Hold for Eli Lilly?
- How to Use the MarketBeat Stock Screener
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.